M. Anaya-Ruiz

发表

Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines.

I. Ilizaliturri-Flores, J. Luna-Arias, E. Lara-Padilla, 2015, International journal of clinical and experimental pathology.

Effect of botulinum neurotoxin type A (BoNTA) on the morphology and viability of 3T3 murine fibroblasts.

E. Lara-Padilla, C. Bandala, A. Alfaro-Rodríguez, 2015, International journal of clinical and experimental pathology.

Synaptic vesicle protein 2 (SV2) isoforms.

J. Luna-Arias, E. Lara-Padilla, C. Bandala, 2012, Asian Pacific journal of cancer prevention : APJCP.

Innovation status of gene therapy for breast cancer.

M. Anaya-Ruiz, Martin Perez-Santos, 2015, Asian Pacific journal of cancer prevention : APJCP.

Evaluation of Serum Levels and Expression of Galectin-4 in Cervical Cancer

A. López-Colombo, J. Reyes-Leyva, V. Vallejo-Ruiz, 2020 .

Entamoeba histolytica: tyrosine kinase activity induced by fibronectin through the beta1-integrin-like molecule.

P. Talamás-Rohana, V. Hernández-Ramírez, M. Anaya-Ruiz, 2000, Experimental parasitology.

Membrane-bound acid phosphatase (MAP) from Entamoeba histolytica has phosphotyrosine phosphatase activity and disrupts the actin cytoskeleton of host cells

M. Aguirre-García, P. Talamás-Rohana, M. Anaya-Ruiz, 2003, Parasitology.

Synaptic vesicle protein isoforms ( SV 2 A , SV 2 B , SV 2 C ) : expression in breast cancer and their association with risk factors and metastasis in Mexican women

Rebeca, I. Ilizaliturri-Flores, R. Uribe-Escamilla, 2017 .

Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1

I. Herrera-Camacho, Lourdes Millán-Pérez Peña, C. Bandala, 2019, Expert opinion on therapeutic patents.

An ecto-protein tyrosine phosphatase of Entamoeba histolytica induces cellular detachment by disruption of actin filaments in HeLa cells.

P. Talamás-Rohana, M. Anaya-Ruiz, J. L. M. Pérez-Santos, 2003, International journal for parasitology.

Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line.

E. Lara-Padilla, C. Bandala, M. Anaya-Ruiz, 2013, Asian Pacific Journal of Cancer Prevention.

In Vitro Anti-Tubulin Activity on MCF10A Cell Line and In Silico Rigid/Semiflexible-Residues Docking, of Two Lignans from Bursera Fagaroides var. Fagaroides

C. Millán-Pacheco, V. Rodríguez-López, J. González-Christen, 2021, Molecules.

Entamoeba dispar contains but does not secrete acid phosphatase as does Entamoeba histolytica.

M. Aguirre-García, P. Talamás-Rohana, J. L. Rosales-Encína, 1999, Experimental parasitology.

Autokinase activities in Entamoeba histolytica induced by extracellular matrix components.

P. Talamás-Rohana, M. Anaya-Ruiz, 2000, Archives of medical research.

Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools

Rebeca D Martínez-Contreras, N. Martínez-Montiel, M. Anaya-Ruiz, 2017, Genes.

Mitochondrial dynamics and cancer

Á. Marín-Hernández, P. Maycotte, J. Reyes-Leyva, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment

Rosana Pelayo, I. Herrera-Camacho, P. Maycotte, 2019, Front. Oncol..

Bursera copallifera Extracts Have Cytotoxic and Migration-Inhibitory Effects in Breast Cancer Cell Lines

D. Moreno, F. Ferreres, P. Maycotte, 2018, Integrative cancer therapies.

LAG-3 antagonists by cancer treatment: a patent review

N. Villa‐Ruano, C. Bandala, M. Anaya-Ruiz, 2019, Expert opinion on therapeutic patents.

Treatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1

I. Herrera-Camacho, M. Anaya-Ruiz, J. Cebada, 2019, Expert opinion on therapeutic patents.

Drug repurposing of adapalene for melanoma treatment.

M. Anaya-Ruiz, Martin Perez-Santos, 2022, Pharmaceutical patent analyst.

miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line.

M. Anaya-Ruiz, J. Cebada, Guadalupe Delgado-López, 2013, Asian Pacific journal of cancer prevention : APJCP.

Colon carcinoma treatment using bispecific anti-GITR/CTLA-4 antibodies: a patent evaluation of WO2018091739

I. Herrera-Camacho, Lourdes Millán-Pérez Peña, C. Bandala, 2020, Expert opinion on therapeutic patents.

Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents

M. Anaya-Ruiz, Luis Villafaña-Diaz, Martin Perez-Santos, 2022, Expert opinion on drug discovery.

Small-molecule inhibitor PD-1/PD-L1 interaction for colorectal cancer treatment.

M. Anaya-Ruiz, Martin Perez-Santos, 2021, Pharmaceutical patent analyst.

Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.

C. Bandala, J. Sarracent-Pérez, M. Anaya-Ruiz, 2019, Recent patents on anti-cancer drug discovery.

Bispecific anti-OX40/CTLA-4 antibodies for advanced solid tumors: a patent evaluation of WO2018202649

N. Rosas-Murrieta, I. Herrera-Camacho, Lourdes Millán-Pérez Peña, 2019, Expert opinion on therapeutic patents.

OX40 agonists for cancer treatment: a patent review

A. Flores, N. Rosas-Murrieta, I. Herrera-Camacho, 2020, Expert opinion on therapeutic patents.

Global patent landscape in breast cancer metastasis

M. Anaya-Ruiz, Martin Perez-Santos, 2018, Chronicles of Oncology.

miR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells.

C. Bandala, M. Anaya-Ruiz, J. L. M. Pérez-Santos, 2013, Asian Pacific journal of cancer prevention : APJCP.

Neural Transdifferentiation: MAPTau Gene Expression in Breast Cancer Cells.

E. Lara-Padilla, C. Bandala, A. Alfaro-Rodríguez, 2016, Asian Pacific journal of cancer prevention : APJCP.

Cervical cancer trends in Mexico: incidence, mortality and research output.

M. Anaya-Ruiz, Analisa Vincent, Martin Perez-Santos, 2014, Asian Pacific journal of cancer prevention : APJCP.

Cancer combinatorial immunotherapy using etigilimab and nivolumab: a patent evaluation of WO2018102536

N. Rosas-Murrieta, I. Herrera-Camacho, Lourdes Millán-Pérez Peña, 2019, Expert opinion on therapeutic patents.

Female breast cancer incidence and mortality in Mexico, 2000-2010.

L. Flores-Mendoza, V. Vallejo-Ruiz, M. Anaya-Ruiz, 2014, Asian Pacific journal of cancer prevention : APJCP.

Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1

I. Herrera-Camacho, Lourdes Millán-Pérez Peña, M. Anaya-Ruiz, 2019, Expert opinion on therapeutic patents.

Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19

Itzel Jatziri Contreras-García, N. Cárdenas-Rodríguez, C. Bandala, 2023, Current neuropharmacology.

Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents.

C. Bandala, M. Anaya-Ruiz, Martin Perez-Santos, 2016, Recent patents on anti-cancer drug discovery.

Mexican breast cancer research output, 2003-2012.

M. Anaya-Ruiz, J. L. M. Pérez-Santos, 2013, Asian Pacific journal of cancer prevention : APJCP.